Physician profile
Yolanda Gates
NPI 1861639809
$1,930.20
in general payments reported to CMS, 2019-2025
19 companies · $340 in 2025
The $340 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $154 · 2022: $513 · 2023: $271 · 2024: $652 · 2025: $340.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,263.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,263.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $572.10 | 2023-2025 | Barostim Neo System |
| Abbott Laboratories | $304.49 | 2021-2024 | Cardiomems |
| Janssen Pharmaceuticals, INC | $205.69 | 2021-2024 | Xarelto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $142.37 | 2022-2024 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $139.76 | 2021-2025 | Lifevest |
| Pfizer INC. | $135.70 | 2022-2025 | |
| Baxter Healthcare | $84.27 | 2023-2024 | Floseal, Coseal, Preveleak |
| Merck Sharp & Dohme LLC | $70.23 | 2021-2022 | |
| Alnylam Pharmaceuticals INC. | $50.05 | 2023-2025 | Amvuttra |
| Astrazeneca Pharmaceuticals LP | $44.61 | 2021-2024 | Farxiga |
| Shockwave Medical, INC | $35.66 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Octapharma USA, INC. | $24.89 | 2025 | Fibryga |
| Atricure, INC. | $19.85 | 2022 | |
| Novo Nordisk INC | $19.17 | 2023 | Ozempic, Rybelsus |
| Medtronic, INC. | $18.10 | 2024 | Evera Mri Xt Dr Surescan |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $16.48 | 2022 | |
| Terumo Medical Corporation | $16.12 | 2024 | Glidewire, Navicross |
| Kls-Martin L.P. | $15.46 | 2025 | |
| Axonics, INC. | $15.20 | 2024 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yolanda Gates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.